Lynn Kerr

Lynn Kerr is an experienced regulatory affairs professional currently serving as the Regulatory Affairs Director at AstraZeneca since October 2017. Prior roles include Associate Regulatory Project Director at MedImmune from January 2009 to October 2017, where Lynn also worked as Manager, Regulatory Affairs Project Management and CMC/Quality Aspect Analyst. Previous positions include Medical Writer at Thermo Fisher Scientific, Senior Manager of the Mycoplasma Laboratory and Viral Clearance Laboratory at BioReliance, as well as Manager of Clinical Trial Support at BioReliance in Scotland. Lynn earned a BSc in Microbiology from the University of Dundee, completing studies from 1990 to 1994.